Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 5,044 shares at $23.22 ($117K) on 2023-08-23, disclosed to the SEC on 2023-08-25.
Seasonal sale ($117k) by Chief Medical Officer — this insider has traded DNLI in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.22 | 2,522 | $59K | 50.0% |
| 2 | $23.22 | 2,522 | $59K | 50.0% |
| Total | $23.22 avg | 5,044 | $117K | 100% |
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |